Generics giant Teva Pharmaceuticals has been hit with another fine related to its blockbuster multiple sclerosis drug Copaxone, this time by the European Commission. Teva will …
Author :
Publish date : 2024-10-31 12:28:00
Copyright for syndicated content belongs to the linked Source.
The post Teva fined €462.6M by European regulators over Copaxone patent and competition allegations first appeared on Love Europe.
Author : love-europe
Publish date : 2024-10-31 19:45:10
Copyright for syndicated content belongs to the linked Source.